Please assess the completion status of the following clinical trial:

Trial Title: Use Of Fragmin In Hemodialysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* chronic renal failure on hemodialysis~Exclusion Criteria:~* significant comorbidities that would prevent a patient from completing the trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Fragmin (Type: EXPERIMENTAL): Fragmin given according to the flexible dosing regimen outlined in the protocol

Based on this trial design, predict the completion outcome and termination type (if applicable).